Phospholipid biosynthesis pathway enzyme (None established (individual enzymes may have abbreviations, e.g., GPAT, AGPAT, PSS, PSD, CT, Pmt))

Phospholipid biosynthesis pathway enzymes are a collection of lipid-transforming proteins that catalyze the sequential synthesis of membrane phospholipids—core constituents of all cellular membranes. These enzymes act at distinct steps such as acyltransferase reactions adding fatty acids to backbone molecules (e.g., GPAT, AGPAT), synthase steps assembling phospholipid headgroups (e.g., PSS for phosphatidylserine, PIS for phosphatidylinositol), decarboxylase and methyltransferase steps modifying headgroups (e.g., PSD, Pmt), and kinases/cytidylyltransferases activating intermediates (e.g., CT for CDP-choline). The pathways are tightly regulated by substrate availability, metabolic cross-talk, post-translational modifications, and transcriptional control[1][3][7][9]. Their activity determines membrane composition, flexibility, and signaling capacity, with disruption implicated in diverse human diseases. While this class includes several possible therapeutic targets, the name itself is generic and refers to a pathway collection—not one individual molecule. Note: This entry describes a set of enzymes—specific molecular targets should be queried with their unique names, e.g., “Phosphatidylserine synthase” or “Phosphatidylcholine synthase,” for precise target identification.

Other names

Kennedy pathway enzymeCDP-DAG pathway enzymeGlycerol-3-phosphate acyltransferase (GPAT)Acylglycerol-3-acyltransferase (AGPAT)Phosphatidylserine synthase (PSS)Phosphatidylserine decarboxylase (PSD)CTP:phosphocholine cytidylyltransferase (CT)Phospholipid N-methyltransferase (Pmt)PlsB, PlsC, PlsX, PlsY (bacterial orthologs)

Competitive inhibition of enzyme active sites. Allosteric inhibition. Substrate analogs disrupting pathway flux. Lipid mimetics interfering with synthesis or incorporation.